Management of Recurrent Gastrointestinal Stromal Tumors

被引：15

作者：

Winer, Joshua H. ^{[1
,2
]}

Raut, Chandrajit P. ^{[1
,2
,3
]}

机构：

[1] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 08期

关键词：

recurrent gastrointestinal stromal tumor; imatinib mesylate; sunitinib malate; surgery; neoadjuvant therapy; blood level testing; PHASE-II TRIAL; IMATINIB MESYLATE; SURGICAL RESECTION; RESIDUAL DISEASE; TYROSINE-KINASE; DOSE IMATINIB; GIST; THERAPY; SURGERY; KIT;

D O I：

10.1002/jso.21890

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recurrence after resection of primary gastrointestinal stromal tumor (GIST) is an unfortunately all-too-common phenomenon. The principal treatment for recurrent GIST is the first-line tyrosine kinase inhibitor (TKI) imatinib mesylate. Those who progress on, or are intolerant of imatinib, are treated with second-line TKI sunitinib malate. Cytoreductive surgery may be considered as an "adjuvant" therapy for patients with disease stabilized on imatinib, and, on an individual basis, sunitinib. J. Surg. Oncol. 2011;104:915-920. (C) 2011 Wiley Periodicals, Inc.

引用

页码：915 / 920

页数：6

共 50 条

[41] Practical Management of Imatinib in Gastrointestinal Stromal Tumors
Barnes, Tamara
Reinke, Denise
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (05) : 533 - 545
[42] Current surgical management of duodenal gastrointestinal stromal tumors
Lim, Kheng Tian
WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (10): : 1166 - 1179
[43] A guide for the diagnosis and management of gastrointestinal stromal cell tumors
Paul S. Sepe
William R. Brugge
Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 363 - 371
[44] Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors
Gutierrez, Juan C.
De Oliveira, Luiz O. Pita
Perez, Eduardo A.
Rocha-Lima, Caio
Livingstone, Alan S.
Koniaris, Leonidas G.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (03) : 479 - 491
[45] Laparoscopic Management and Longterm Outcomes of Gastrointestinal Stromal Tumors
Tabrizian, Parissa
Nguyen, Scott Q.
Divino, Celia M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (01) : 80 - 86
[46] Current management of gastrointestinal stromal tumors - A comprehensive review
Lai, Eric C. H.
Lau, Stephanie H. Y.
Lau, Wan Yee
INTERNATIONAL JOURNAL OF SURGERY, 2012, 10 (07) : 334 - 340
[47] Evolution of multimodality management of gastrointestinal stromal tumors of the stomach
Bilimoria, K. Y.
Merkow, R. P.
Wayne, J. D.
Abbott, D. E.
Cormier, J. N.
Feig, B. W.
Hunt, K.
Pisters, P. W.
Pollock, R. E.
Bentrem, D. J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[48] Advances of endoscopic and surgical management in gastrointestinal stromal tumors
Yue, Lei
Sun, Yingchao
Wang, Xinjie
Hu, Weiling
FRONTIERS IN SURGERY, 2023, 10
[49] Molecular research directions in the management of gastrointestinal stromal tumors
Tarn C.
Godwin A.K.
Current Treatment Options in Oncology, 2005, 6 (6) : 473 - 486
[50] The rote of KIT in the management of patients with gastrointestinal stromal tumors
Hornick, Jason L.
Fletcher, Christopher D. M.
HUMAN PATHOLOGY, 2007, 38 (05) : 679 - 687

← 1 2 3 4 5 →